World

First International Conference on Eustachian Tube Research & Interventions concludes

Apr 14, 2025

Dubai [UAE], April 14: The First International Conference on Eustachian Canal Research and Interventions, held on the sidelines of the twentieth conference of the Middle East Academy of Ear, Nose and Throat, concluded its activities at the Intercontinental Hotel Dubai
The event saw tolaryngology and researchers focused on the function of the Eustachian tube and dysfunction, to address some of the most pressing and often neglected challenges in this field.
Dr. Muath Tarabishi, President of the Conference, stressed the importance of hosting the event in the UAE, stressing that Dubai has become a milestone in the region as a centre for advanced care and research in ear, nose and throat, noting that hosting this global conference here highlights our commitment not only to follow-up but to leadership in this vital field.
He said the conference uncovered discussed uncovered aspects of Eustachian tube diseases, diagnostic inconsistencies, and the need for more nuanced approaches across age groups, expecting these discussions to shape the next wave of clinical innovation and improved care for patients worldwide.
Dr. Dennis Poe, former IWGET chair and associate professor at Harvard Medical School, added the meeting highlighted the most pressing clinical questions in Eustachian Canal research. We are aligning our efforts to pursue evidence-based answers that will benefit patients globally."
Source: Emirates News Agency

More news

Infosys: Differentiated AI strategy and a sharp focus on value unlock propels 29% sequential growth in AI revenues

Bengaluru (Karnataka) [India], October 23: Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in AI-first business consulting and technology services, delivered $5,145 million in Q2 revenues, year on year growth of 1.5% and sequential growth of 1.2% in constant currency. Operating margin was stable at 21.0%. EPS growth was 8.7% year on year in rupee terms. TCV of large deal wins was $5.2 billion, with 62% net new. Robust Q2 large deal TCV at $5.2 billion with 62% net new; lays solid foundation for future growth. FY 27 revenue guidance revised to 1%-2% and margin guidance retained at 20%-22%.

Oct 23, 2026